The Canadian Gene & Cell Therapy (GCT) Conference is now accepting abstract submissions highlighting advances across the gene and cell therapy landscape.**

Accepted abstracts will be presented as posters, with selected submissions invited for short oral presentations. The conference aims to showcase cutting-edge science, foster interdisciplinary collaboration, accelerate translation, and strengthen Canada’s gene and cell therapy ecosystem.

We welcome submissions spanning basic discovery through clinical implementation. 

We can’t wait to showcase the incredible work happening across the gene and cell therapy community! Once you’ve completed your conference registration, you’ll receive a link to submit an abstract for consideration as a poster or oral presentation.

Click here to register, and select Yes to submit an abstract on the registration form.

Deadline to submit has been extended from October 1 to October 15, 2026.

**Eligible abstracts include but are not limited to trainees, researchers, early career investigator, research fellows, clinicians, industry and more.